CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $844K invested in Can-Fite BioPharma in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$756K
2
+$6.73K

Top Sellers

1
-$20.1K
2
-$16.5K
3
-$7.36K
4
UBS Group
UBS Group
Switzerland
-$360
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$245
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$756K
2
$76.5K
3
$6.87K
4
$1.64K
5
$1.35K
6
$1.27K
7
$121
8
$59
9
–
10
–
11
–
12
–